Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer
Year: 2018
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Immune infiltration is implicated in the development of acquired resistance to anti-angiogenic cancer therapy. We therefore investigated the correlation between neutrophil infiltration in metastasis of colorectal cancer (CRC) patients and survival after treatment with bevacizumab. Our study identifies CD177+ tumour neutrophil infiltration as an adverse prognostic factor for bevacizumab treatment. We further demonstrate that a novel anti-VEGF/anti-Ang2 compound (BI-880) can overcome resistance to VEGF inhibition in experimental tumour models. METHODS: A total of 85 metastatic CRC patients were stratified into cohorts that had either received chemotherapy alone (n = 39) or combined with bevacizumab (n = 46). Tumour CD177+ neutrophil infiltration was correlated to clinical outcome. The impact of neutrophil infiltration on anti-VEGF or anti-VEGF/anti-Ang2 therapy was studied in both xenograft and syngeneic tumour models by immunohistochemistry. RESULTS: The survival of bevacizumab-treated CRC patients in the presence of CD177+ infiltrates was significantly reduced compared to patients harbouring CD177- metastases. BI-880 treatment reduced the development of hypoxia associated with bevacizumab treatment and improved vascular normalisation in xenografts. Furthermore, neutrophil depletion or BI-880 treatment restored treatment sensitivity in a syngeneic tumour model of anti-VEGF resistance. CONCLUSIONS: Our findings implicate CD177 as a biomarker for bevacizumab and suggest VEGF/Ang2 inhibition as a strategy to overcome neutrophil associated resistance to anti-angiogenic treatment.
Source: British Journal of Cancer
Authors: Lars Mortimer Schiffmann, Melanie Fritsch, Florian Gebauer, Saskia Diana Günther, Neil Richard Stair, Jens Michael Seeger, Fabinshy Thangarajah, Georg Dieplinger, Marc Bludau, Hakan Alakus, Heike Göbel, Alexander Quaas, Thomas Zander, Frank Hilberg, Christiane Josephine Bruns, Hamid Kashkar, Oliver Coutelle
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,190
Awards: G1506585195, G3202839542, G602815544
OpenAlex ID: W2899252841
